I Read The News Today Oh Boy! 4-Sep-2017

Monday, Sep 04 2017 by

Morning all!

Blancco Technology (BLTG)Update On Revenue And Management – This “provider of mobile device diagnostics and secure data erasure solutions” is Loss making and has Debt AND I don’t like the look of this…


Bioventix plc (BVXP)Trading Update, Notice Of Results And AGM – This is a company “specialising in the development and commercial supply of high-affinity monoclonal antibodies for application in clinical diagnostics, announces a trading update”. This brief update is encouraging…


Current Revenue estimates seem to be around the £6.3m level so this news may well provide this share with even more tailwind – It’s up 100% YTD. Kicking myself for not getting in here when it was below 2000p admittedly put off by the, at the time, PER of 25! Hats off to those in on the ride.

Concurrent Technologies (CNC) – EXPECTED NEWS BUT FOUND NONE - HERE'S MY NOTES ANYWAY – I like a company with Cash and this “manufacture of embedded computer products for applications in the defense, aerospace, transportation, telecommunications, scientific and industrial markets” has 15% of Mkt Cap in reserves. Figures look OK too, even if they are not really growing much. ROCE is 15% and the modest (2.8%) Dividend is well covered. However on a PER of 16 I consider Revenue, Profit and EPS CAGRs <=3.5% to be rather poor.

EVR Holdings (EVRH) – EXPECTED NEWS BUT FOUND NONE - HERE'S MY NOTES ANYWAY – A company that provides customers with “audiovisual and interactive material intended for use with virtual reality devices”.  Never made a profit and with a StockRank of 4 – I will leave this Highly Speculative Sucker Stock to the speculators and suckers.

Kainos Group (KNOS) – Trading Update For The Period April To August 2017 – This “leading provider of Digital Services and Platforms” expects results to be in-line with current market expectations. This is a new company to me and it looks OK – Even having doubled in the past 12 months. The PER of 26 seems about right based on the current growth – It’s on my “possible market correction buy list”.

Tax Systems (TAX)Interim Results For The 6 Months Ended June 2017

Unlock this article instantly by logging into your account

Don’t have an account? Register for free and we’ll get out your way


As per our Terms of Use, Stockopedia is a financial news & data site, discussion forum and content aggregator. Our site should be used for educational & informational purposes only. We do not provide investment advice, recommendations or views as to whether an investment or strategy is suited to the investment needs of a specific individual. You should make your own decisions and seek independent professional advice before doing so. The author may own shares in any companies discussed, all opinions are his/her own & are general/impersonal. Remember: Shares can go down as well as up. Past performance is not a guide to future performance & investors may not get back the amount invested.

Do you like this Post?
25 thumbs up
0 thumbs down
Share this post with friends

Bioventix PLC is a United Kingdom-based biotechnology company. The principal activity of the Company is the development and supply of antibodies. The Company specializes in the development of sheep monoclonal antibodies (SMAs) for use in immunodiagnostics focusing on the areas of clinical diagnostics and drugs of abuse testing. The Company's non-vitamin D business consists of antibodies, NT proBNP (heart failure), testosterone, Free Triiodothyronine (FT3) (thyroid hormone), estradiol, and various drugs, such as tetrahydrocannabinol (THC)/cannabis, and progesterone. The Company offers products for indications, such as thyroid, fertility, oncology, cardiac, vitamin D, drug of abuse, infectious disease and miscellaneous. Its sheep hybridoma technology produces cell lines that secrete SMAs. The Company offers a panel of SMAs to 25-OH D and has various 25-OH D2 and 25-OH D3 specific antibodies. It sells its products through direct sales and through distributors. more »

LSE Price
Mkt Cap (£m)
P/E (fwd)
Yield (fwd)

Kainos Group plc is a digital services company. The Company offers information technology products and services to clients in a range of markets, including government, healthcare and financial services. Its segments include Digital Services, Evolve and WorkSmart. The Digital Services segment delivers various system developments of customized online digital solutions for the United Kingdom government and private sector organizations. The Evolve segment is its software platform, which provides over two offerings to the healthcare markets: Evolve electronic medical records (EMR), which is used for digitization, storage and workflow of patient records, and is engaged in the digitization of patient notes in the Acute sector of the national health service (NHS), and Evolve Integrated Care, a cloud-based integrated care solution. The WorkSmart segment provides consulting, project management, integration, support and testing services. It provides software design and development services. more »

LSE Price
Mkt Cap (£m)
P/E (fwd)
Yield (fwd)

Blancco Technology Group Plc, formerly Regenersis Plc, is a provider of mobile device diagnostics and secure data erasure solutions. The Company's segments include Erasure and Diagnostics. The Erasure segment focuses on development and delivery of solutions, and includes Blancco, which provides erasure software; SafeIT, which is engaged in cloud and networked data erasure business, and Tabernus, which is engaged in providing software erasure products. The Diagnostic segment includes Xcaliber Technologies, a smartphone diagnostics software business. Its secure data erasure solutions include Blancco Management Console, Blancco Cloud, Blancco File, Blancco 5, Blancco Mobile Solutions, Enterprise Erase E800, Enterprise Erase E2400, Enterprise Erase Mobile and Ontrack Eraser Degausser. Its mobile diagnostics solutions include fault diagnostics, repair and program enablement. It serves manufacturers, financial institutions, healthcare providers and government organizations across the world. more »

LSE Price
Mkt Cap (£m)
P/E (fwd)
Yield (fwd)

  Is LON:BVXP fundamentally strong or weak? Find out More »

8 Posts on this Thread show/hide all

Ramridge 4th Sep '17 1 of 8

Morning matylda - BNN Technology (LON:BNN) suspended - CFO resigns making serious allegations, resulting in suspension of UK CEO and China CEO.
Well if some people don't listen to commentators saying never to invest in AIM listed Chinese companies, then they will get fingers burnt again and again.

| Link | Share | 1 reply
matylda 4th Sep '17 2 of 8

In reply to post #214718

Ouch! Thanks for pointing that out.

Agreed, Agreed, Agreed - A loss making AIM listed Chinese company that is classified as a "Highly Speculative Sucker Stock" with a StockRank of 1 - Holders should be ashamed of themselves, even more so now.

Blog: Briefed Up
| Link | Share
mpjubb 4th Sep '17 3 of 8

RE Redcentric (LON:RCN), their CEO "resigned" recently but is staying on until the end of the year. Steve Vaughn has been recently drafted in to try and turn the company around, which is what he does. It will be interesting to see if there is any change in another 3 months...

| Link | Share
doug2500 4th Sep '17 4 of 8

I had to push myself to buy Bioventix (LON:BVXP) a year ago, it was the most expensive share I'd bought by most common metrics. It's worked out rather well......

| Link | Share | 1 reply
matylda 4th Sep '17 5 of 8

In reply to post #214748

Next time push me too :) Nice buy!

Blog: Briefed Up
| Link | Share
BlueFrew 4th Sep '17 6 of 8

Bioventix (LON:BVXP) has always looked expensive, not helped by an often sizeable spread. My first purchase took me well outside my comfort zone paying 650p in October 2014. It does however have qualities few companies possess. Their royalty model means once the R&D and approvals are complete, the money rolls in with little effort from that point on. Replacing their products would be difficult, costly and take time for something that represents a small part of the payment for each test. The management team under promise and usually over deliver.

I'm assuming today's RNS means that the roll out of Siemen's troponin test is going well. That should be very positive for future revenues.

On the other hand, a slightly odd announcement from Central Asia Metals (LON:CAML) . Nobody seems to have a clue as to the identity of the other party in the reverse takeover discussions. Can't do anything about it now anyway with the shares having been suspended.

(Long Bioventix (LON:BVXP) and Central Asia Metals (LON:CAML) )

| Link | Share
crazycoops 4th Sep '17 7 of 8

News from 3 of my top 10 holdings today

Bioventix (LON:BVXP) - excellent news as others have stated and Finncap have today increased their eps forecast to 90p

Central Asia Metals (LON:CAML) - I am as confused as everyone else, not thrilled with the suspension but will have to wait and see what transpires

SafeCharge International (LON:SCH) - confirmation of CFO appointment (as previously signalled) but more interestingly is a M&A specialist has been recruited at VP level. Maybe they will become an acquirer in the sector consolidation that is occurring? I had anticipated they would be a takeover target themselves but maybe not.

All eyes on IQE (LON:IQE) tomorrow - for once I will be setting the alarm clock!

Blog: Share Knowledge
| Link | Share
garbetklb 4th Sep '17 8 of 8

CAML - what I especially didn't like was the mention of "futher announcements in the coming WEEKS". So looks like we're suspends for quite some while.
I hold

| Link | Share

Please subscribe to submit a comment

 Are LON:BVXP's fundamentals sound as an investment? Find out More »

Stock Picking Tutorial Centre

Let’s get you setup so you get the most out of our service
Done, Let's add some stocks
Brilliant - You've created a folio! Now let's add some stocks to it.

  • Apple (AAPL)

  • Shell (RDSA)

  • Twitter (TWTR)

  • Volkswagon AG (VOK)

  • McDonalds (MCD)

  • Vodafone (VOD)

  • Barratt Homes (BDEV)

  • Microsoft (MSFT)

  • Tesco (TSCO)
Save and show me my analysis